Therakind, founded in 2006, is dedicated to improving access to safe and effective specialized medicines for children and underserved patient groups. The company's slogan, "Enhancing access to safe and effective specialized medicines for children and underserved patient groups by addressing unmet medical needs," encapsulates its mission. Therakind operates in the Health Care and Pharmaceutical industries, with its headquarters located in the United Kingdom. The most recent investment was a Venture Round investment on 01 January 2015, with UCLB as the investor. Therakind identifies unmet medical needs in underrepresented patient populations and focuses on creating, developing, and enhancing medicines to address these gaps.
No recent news or press coverage available for Therakind Limited.